Seeing Is Believing
Currently out of the existing stock ratings of Daniel Brennan, 15 are a HOLD (55.56%), 9 are a BUY (33.33%), 3 are a SELL (11.11%).
Analyst Daniel Brennan works at UBS with a stock forecast success ratio of 66.42% fulfilled within 148.89 days on average. Previously, Daniel Brennan worked at COWEN.
Daniel Brennan’s has documented 223 price targets and ratings displayed on 18 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on AVTR, Avantor at 14-Sep-2022.
Analyst best performing recommendations are on NVTA (INVITAE CORP).
The best stock recommendation documented was for ILMN (ILLUMINA) at 9/22/2020. The price target of $285 was fulfilled within 2 days with a profit of $16.49 (6.14%) receiving and performance score of 30.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
102
$11.77 (13.04%)
70
1 months 17 days ago
1/2 (50%)
$13.67 (15.48%)
76
Hold
81
$-9.23 (-10.23%)
78
2 months 4 days ago
6/6 (100%)
$1 (1.25%)
168
Buy
90
$-0.23 (-0.25%)
65
2 months 4 days ago
3/4 (75%)
$10 (12.50%)
104
Hold
62
$-28.23 (-31.29%)
79
5 months 15 days ago
4/4 (100%)
$3.26 (5.55%)
290
Sell
59
$-31.23 (-34.61%)
70
6 months ago
3/3 (100%)
$-1.09 (-1.81%)
236
What Year was the first public recommendation made by Daniel Brennan?